Objective: Kaposi's sarcoma (KS) is a neoplasm strongly associated with HIV-1 infection and marked by leukocytic infiltration. The infiltrating leukocytes are a possible source of inflammatory cytokines, human herpesvirus 8 (HHV8) and the HIV-1 transactivator protein Tat. This study examines whether Tat directly induces expression of cellular adhesion molecules and cytokines in KS cells and whether this induction differs in kinetics and magnitude from induction by tumour necrosis factor (TNF) α.
Introduction
AIDS-associated Kaposi's sarcoma (AIDS-KS) is the predominant neoplasm that occurs in individuals infected with HIV-1. The lesions of KS are multifocal, proliferative vascular lesions of mesenchymal origin that are characterized by abnormal angiogenesis, leukocytic infiltration and proliferation of spindle cells, fibroblasts and endothelium [1] [2] [3] . Experimental evidence suggests that the abnormal proliferation and phenotype of KS cells may result from both changes intrinsic to the KS cells [4, 5] , including infection with human herpesvirus 8 (HHV8) [6, 7] , and changes induced by locally elevated cytokines and growth factors such as oncostatin M [8] , tumour necrosis factor (TNF) α, interleukin 6 (IL-6) [9] and basic fibroblast growth factor (bFGF) [10] .
Although not necessary for the development of KS, infection with HIV-1 is associated with at least a 20 000-fold increase in the incidence of KS among persons with AIDS [11] . HIV-1-infected leukocytes are present in KS lesions [12] , and these cells are likely to release the HIV regulatory protein Tat into the extracellular environment where it can be taken up by neighbouring cells [13] . Tat is found to localize within KS lesions [14] , and several lines of experimental evidence indicate that Tat may contribute to the development of KS. Skin lesions that resemble KS develop in some Tat transgenic mice [15] [16] [17] , and Tat stimulates KS cells and cytokine-activated endothelial cells to undergo steps involved in angiogenesis [18] . Tat also synergizes with bFGF in inducing angiogenic KS-like lesions when both are injected subcutaneously into nude mice [14] . Tat is best known as a potent transactivator of HIV-1 gene expression that interacts with an RNA stem-loop structure known as TAR present on all HIV-1 transcripts [19, 20] and promotes elongation during transcription [19, [21] [22] [23] . Tat also can transactivate some other viral promoters [24, 25] and some cellular genes such as TNFβ, IL-6 and transforming growth factor (TGF) β [26] [27] [28] both through interactions with regions that resemble TAR [27] and through distinct mechanisms [29] . Tat also mediates some changes in cellular function through interactions with extracellular receptors. For example, the proliferation of cultured KS cells in response to Tat occurs through an interaction of its RGD domain with integrins [30, 31] , and Tat promotes angiogenesis, in part, through its binding to and activation of the receptor for vascular endothelial growth factor-A, Flk-1/KDR [32] . Tat also can activate the transcription factor NF-κB through mechanisms that are not well characterized [33] . Thus, Tat is a complex molecule that has multiple potential mechanisms of action.
Tat was recently reported to induce elevated levels of IL-6, E-selectin, vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) proteins in human umbilical vein endothelial cells [34, 35] . These same proteins are expressed at elevated levels in KS lesions [9, 36] and are likely to contribute to the disease process. VCAM-1 binds to the counter-receptor very late antigen (VLA) 4 expressed primarily on monocytes and lymphocytes whereas ICAM-1 binds to counter-receptor leukocyte function associated antigen 1 (LFA-1) expressed on a variety of leukocytes [37, 38] . Through such interactions, cellular adhesion molecules regulate the numbers and types of leukocyte that accumulate in an area of inflammation. Chemokines and cytokines are also involved in regulating inflammatory cell infiltration. The chemokine monocyte chemoattractant protein 1 (MCP-1) specifically attracts monocytes to areas where it is expressed [37, 39] and the cytokine IL-6 activates a number of leukocytes and directly induces KS proliferation [40, 41] .
In the current studies, we examine the link between Tat, inflammatory cytokines and cellular adhesion molecule expression in cultured KS cells. We demonstrate that Tat induces high levels of ICAM-1, VCAM-1, MCP-1 and IL-6 at both the mRNA and protein levels. Both Tat and TNFα activate comparable levels of the transcription factor NF-κB, yet Northern blot analysis indicates that Tat induces earlier increases and much higher levels of most of these mRNA forms than does TNFα, suggesting that the Tat-mediated increases in mRNA result in part from a mechanism that is distinct from that utilized by TNFα.
Materials and methods
Cell culture KS cells were obtained from punch biopsies of clinically involved skin from HIV-1 infected individuals. The biopsies were finely minced and plated onto gelatin-coated plates in RPMI 1640 media (Mediatech, Inc., Herndon, Virginia, USA) supplemented with 10% fetal calf serum (FCS) (Hyclone Laboratories, Inc., Logan, Utah, USA), 2 mM L-glutamine (Gibco-BRL, Life Technologies, Inc., Grand Island, New York, USA), 50 µg/ml endothelial cell growth supplement (ECGS) (ICN Biomedical, Irving, California, USA), 16 U/ml heparin (ESI Pharmaceuticals, Cherry Hill, New Jersey, USA), and 100 U/ml penicillin-streptomycin mixture (Gibco-BRL, Life Technologies, Inc.). The phenotype of cells cultured from the KS lesions using these conditions has been previously described [5] . Furthermore, some cells cultured under these contain HHV-8 that can be detected by polymerase chain reaction (PCR) [42] .
KS modified media contained 10% FCS, L-glutamine, and penicillin-streptomycin as above, but it did not contain ECGS or heparin. This media was used for all experiments involving the incubation of KS cells with the HIV-1 Tat protein. Heparin was omitted because of its ability to bind Tat. ECGS uses heparin as a cofactor and was also omitted.
Cytokines and other reagents
The synthetic double-stranded RNA poly(I:C) was obtained from Pharmacia LKB Biotechnology (Piscataway, New Jersey, USA). Human recombinant TNFα was purchased from Boehringer Mannheim (Indianapolis, Indiana, USA). Lipopolysaccharide (LPS) was purchased from Sigma (St Louis, Missouri, USA). Recombinant human HIV-1 Tat protein (Tat 86) was expressed in Escherichia coli and purified to homogeneity as previously described [13, 14] . Lyophilized Tat was then resuspended in degassed buffer [phosphatebuffered saline (PBS) with 0.1% bovine serum albumin (BSA)] and used at the indicated concentrations. For heat inactivation, Tat was incubated at 95 o C at 100× concentration in PBS for 5 min and then placed immediately on ice for 5 min. LPS was processed identically. Parallel samples of Tat and LPS were processed identically without the heat inactivation as controls. The Tat or LPS was then added to modified medium and added to cells.
Flow cytometric analysis of CAM expression
Confluent KS cells were detached with versene (0.2 g EDTA•4Na/l in PBS) (Gibco-BRL, Life Technologies, Inc.) and one-third of each sample was processed with each fluorescein isothiocyanate (FITC)-conjugated antibody. The antibodies used were monoclonal mouse anti-human VCAM-FITC (CD106) at 5 mg/ml, mouse anti-human ICAM-FITC (CD54) at 1 mg/ml and a FITC-conjugated non-reactive goat anti-mouse immunoglobulin (Ig) G at 16 mg/ml. All antibodies were obtained from Ancell (Bayport, Minnisota, USA). Samples were incubated with the antibodies for 30 min at 4 o C followed by two PBS washes. Cells were resuspended in PBS and fixed with an equal volume of 2% paraformaldehyde in PBS. Relative immunofluorescence was quantified by flow cytometry with log amplification utilizing a fluorescence activated cell sorter (FACS scan IV, Becton Dickinson, Mountain View, California, USA).
Quantification of IL-6, MCP-1 and ICAM-1 by ELISA
Cells were grown to confluence in 96-well plates prior to induction. All experiments were performed using the KS modified media. The conditioned medium from the experiments was removed and assayed by ELISA for secreted IL-6 and MCP-1 using commercially available kits according to the manufacturers' instructions (IL-6 from PerSeptive Diagnostics, Cambridge, Massachusetts, USA and MCP-1 from R&D Systems, Minneapolis, Minnesota, USA). Triplicate assays were performed for the calculation of standard deviation.
Cell surface ICAM-1 expression was assayed on live cells by incubation with mouse anti-human ICAM-1 antibody (84H10) at 1 mg/ml in complete medium for 30 min at 37 o C. Wells in which no primary antibody was used were included for background determination. Cells were washed and then incubated for 30 min with peroxidase-conjugated goat-anti-mouse IgG (Biorad, Richmond, California, USA) diluted 1 : 1000 in medium. Cells were then washed three times with PBS to reduce non-specific sticking. Binding of the secondary antibody was assessed by addition of 100 µl 0.1 mg/ml tetramethylbenzidine (Sigma) and 0.3% H 2 O 2 . The reaction was stopped by the addition of 25 µl 4 mol/l sulphuric acid, and the plates were read on a Biorad model 450 ELISA Reader at 450 nm.
RNA isolation and Northern blot analysis
Cells were rinsed with PBS followed by lysis in 2 ml 4 mol/l guanidium isothiocyanate. Total cellular RNA was obtained by ultracentrifugation of guanidium isothiocyanate on a caesium chloride density gradient [43] . The cellular RNA underwent two ethanol precipitations before being used for Northern blot analysis.
Total cellular RNA was size fractionated using 1% agarose formaldehyde gels containing 1 µg/ml ethidium bromide [44] . The RNA was transferred to nitrocellulose and covalently linked by a Stratalinker UV crosslinker (Stratagene, La Jolla, California, USA). Hybridizations and washes were performed using Stratagene QuikHyb hybridization solution according to the manufacturer's instructions. Approximately 1 × 10 7 c.p.m./ml labelled probe (specific activity > 10 8 c.p.m./µg DNA) was used for each hybridization. Autoradiography was performed using an intensifying screen at -80 o C. Quantification of mRNA levels was performed using a Bio-Rad Phosphorimager.
DNA probes
DNA probes labelled with phosphous-32 were generated using the OLB random primed oligonucleotide labelling kit purchased from Pharmacia LKB Biotechnology. The IL-6 probe was 1.0 kb EcoR1 fragment of complimentary (c) DNA excised from clone pXM309 [45] . The VCAM-1 probe was obtained from a HindIII-XhoI fragment of cDNA representing nucleotides 132-1314 [46] . The ICAM-1 probe was generated from an EcoRI digestion of human cDNA [47] .
Isolation of nuclear extracts and Electrophoretic Mobility Shift Assay (EMSA)
Cells were washed with PBS, detached using Versene, pelleted by centrifugation and resuspended by pipetting gently in Buffer A (10 mmol/l HEPES pH 8.0, 1.5 mmol/l MgCl 2 , 10 mmol/l KCl, 200 mmol/l sucrose, 0.05% NP-40 and 0.5 mmol/l DTT containing protease inhibitors at the following concentrations: 1 µg/ml aprotonin, 0.7 µg/ml pepstatin, 0.3 µg/ml antipain, 1 µg/ml leupeptin and 0.5 mmol/l PMSF). The suspensions were incubated for 10 min on ice and then centrifuged. The nuclear pellet was washed once with Buffer A without NP-40. The pellet was resuspended in Buffer B (20 mmol/l HEPES pH 7.4, 25% glycerol, 420 mmol/l NaCl, 1.5 mmol/l MgCl 2 , 0.2 mmol/l EDTA containing the same concentrations of protease inhibitors as Buffer A). The cells were incubated for 30 min on ice and vortexed at half speed every 10 min. After the 30 min incubation, the sample was centrifuged at 14 000 r.p.m. for 10 min. The resulting supernatant was saved as the nuclear extract.
EMSAs were performed using a probe representing the tandem NF-κB elements from the VCAM-1 promoter.
The probe was constructed by placing a primer 5ЈAGGCGGAGGGA-3Ј and template 5Ј-CTGCC CTGGGTTTCCCCTTGAAGGGATTTCCCTCC GCCT-3Ј (NF-κB sites underlined) together in annealing buffer (18 mmol/l Tris pH 7.5, 2 mmol/l MgCl 2 , 50 mmol/l NaCl) and heated for 5 min at 85ºC and allowed to cool to room temperature. After annealing of the primer, the second strand was synthesized using 0.25 mmol/l dATP, dGTP and dTTP, 50 µCi [
32 P]-dCTP and 9 U Klenow. The nonradioactive competitor was made identically except for the use of non-radioactive dCTP at 0.25 mmol/l. Free nucleotides were removed using a Sephadex G25 spin column. The probe was incubated with the indicated concentration of nuclear extract for 20 min at room temperature in binding buffer [0.08 mol/l KCl, 0.016 mol/l HEPES pH 7.9, 5 mmol/l Tris-Cl pH 7.5, 1 mmol/l EDTA pH 8.0, 1 mmol/l DTT, 1 mmol/l PMSF, 33 µg/ml poly(dI:dC), 33 µg/ml salmon sperm DNA and 16% glycerol]. Protein-DNA complexes were resolved from free probe on native 4% Trisglycine polyacrylamide gels [48] .
Results

HIV-1 Tat protein induces expression of multiple inflammatory response genes on cultured KS cells
The cellular adhesion molecules ICAM-1 and VCAM-1 are known to be induced on KS cells by inflammatory mediators such as poly(I:C), IL-1β and TNFα [5, 49] . Flow cytometry was performed to determine if Tat protein could also induce cell adhesion molecule expression on the surface of KS cells. There was no detectable VCAM-1 expression in the control population of KS cells (Fig. 1A) . After incubation with Tat for 20 h, the entire KS cell population displayed induced VCAM-1 expression. The induction by Tat was comparable to that of poly(I:C), an agent known to lead to high levels of VCAM-1 expression on KS cells [5] . ICAM-1 expression was also increased in KS cells that were incubated with Tat (Fig. 1B ). There were low levels of ICAM-1 expressed in control KS cells, and the entire population of cells responded to Tat with increased expression of ICAM-1 on their surface. The increase in expression was comparable to that observed with cells incubated with poly(I:C).
To address the possibility that the observed inductions were caused by a LPS contaminant within the recombinant Tat preparation, both Tat and LPS were heated for 15 min at 95ºC prior to the addition to KS medium. This treatment eliminated the ability of the heat-labile Tat to induce protein expression but did not affect the ability of LPS to induce ICAM-1 expression (Fig. 2A) . The heat sensitivity of Tat and the lack of detectable LPS by limulus assay indicate that Tat-mediated inductions were not caused by a LPS contaminant.
Having determined that the protein expression of two different inflammatory response genes was induced by Tat, we next examined the ability of Tat to induce MCP-1 and IL-6 proteins in cultured KS cells. The cells were incubated with various concentrations of the recombinant HIV-1 Tat protein, and the levels of MCP-1 and IL-6 secreted into the conditioned medium were assayed by ELISA. The levels of MCP-1 found in non-treated control cells were low (Fig. 2B) . In contrast, cells incubated with Tat protein for 20 h showed a significant increase in MCP-1. The increase in MCP-1 levels was detectable using 0.1 µg/ml Tat, with a greater induction being observed using 0.5 µg/ml Tat. Tat at 0.01 µg/ml did not induce MCP-1 protein expression. The induction seen with Tat at the higher concentration (0.5 µg/ml) was comparable to the known inducer poly(I:C) and even greater than that seen with TNFα. The ability of Tat to induce MCP-1 was eliminated when it was heated prior to addition to the medium. Although the 0.5 µg/ml concentration of Tat appeared to lead to a greater induction of protein expression, Tat was used at the concentration 0.1 µg/ml for subsequent experiments since this concentration displayed a clear response.
The effect of Tat on IL-6 protein expression by KS cells was then examined. Cells incubated with the Tat protein (0.1 µg/ml) for 20 h displayed clear induction of IL-6, with even higher levels resulting from incubation with 0.5 µg/ml (Fig. 2C) . The induction of IL-6 protein expression by Tat was less than that with poly(I:C) and comparable to the induction seen with TNFα. Heat treatment of the Tat eliminated the induction of IL-6 secretion.
HIV-1 Tat leads to an increase in mRNA levels for ICAM-1, VCAM-1, MCP-1 and IL-6
To determine the time course and magnitude of induction by Tat at the molecular level, Northern blot hybridizations were performed on total RNA isolated from KS cells incubated with Tat (0.1 µg/ml) or with the positive inducer TNFα (10 ng/ml) for various times. The pattern of message induction in response to the two inducers differed in the time required for peak levels to occur. This was most dramatically illustrated by examining IL-6 mRNA levels (Fig. 3A) . By 2 h, Tat induced high IL-6 mRNA levels that remained elevated at 4 and 18 h. A decrease in IL-6 mRNA was observed at 8 h, suggesting a biphasic pattern of induction by Tat. This pattern contrasts sharply with IL-6 mRNA levels seen in response to TNFα, which did not begin to increase significantly until 18 h. Differences in time course in response to Tat and TNFα were observed with other mRNAs as well.
VCAM-1 mRNA was induced to peak levels by 2 h with Tat, whereas induction by TNFα occurred more gradually (Fig. 3B) . ICAM-1 mRNA was also induced rapidly and to high levels in response to Tat, whereas ICAM-1 was poorly induced by TNFα (Fig. 3C) .
Although IL-6, VCAM-1 and ICAM-1 mRNAs were induced more effectively by Tat than by TNFα, MCP-1 mRNA was as responsive, if not more so, to incubation with TNFα as to Tat. Although some variability in the amount of β-actin mRNA was detected, Fig. 2 . Induction of imflammatory response genes in AIDSassociated Kaposi's sarcoma (KS) by Tat is heat-sensitive. Identical numbers of confluent KS cells were untreated (control) or incubated with the indicated agents for 20 h and assayed for intercellular adhesion molecule 1 (ICAM-1) expression (a) by ELISA using monoclonal antibodies directed against ICAM-1 as described in the Methods. Conditioned media were assayed for monocyte chemoattractant protein (MCP) 1 (b) or interleukin (IL) 6 (c) by sandwich ELISA, as described in the Methods. Data are shown as mean ± standard deviation of measurements from triplicate wells. Fig. 3 . Northern blot analysis of AIDS-associated Kaposi's sarcoma (KS) mRNA expression over time in response to HIV-1 Tat and tumour necrosis factor (TNF) α. Confluent KS cells were incubated with Tat (0.1 µg/ml) or TNFα (10 ng/ml) for the indicated times. Each lane represents 10 µg total cellular RNA that was size fractionated, transferred to nitrocellulose and serially probed as described in the Methods. The ethidium bromide staining of the nitrocellulose that was serially probed is shown in (F) to document amounts of RNA in each lane.
standardization to actin using a phosphoimager for quantification confirmed that for all mRNAs examined, except MCP-1, induction occurred earlier and with higher peak levels in response to incubation with Tat than in response to incubation with TNFα.
Tat and TNFα induce NF-κB binding to the VCAM-1 promoter
The transcription factor NF-κB is, in part, involved in the transcriptional regulation of all four genes under study. To determine whether differences in NF-κB activation might account for differences in mRNA induction observed in response to Tat and TNFα, nuclear extracts from cells treated with Tat or TNFα for 2 h were analysed for NF-κB activation by gel shift analysis. There was a basal level of binding of two NF-κB complexes of different molecular weights (Fig. 4,  bands A and B) . Both Tat and TNFα induced comparable increases in the binding of these NF-κB complexes. The binding of complexes A and B was prevented competitively by an excess (100-fold) of cold specific competitor but not by an unrelated sequence. Supershift analysis indicated that these complexes were composed of p50-containing and a little, if any, p65-containing NF-κB subunits.
Discussion
We provide evidence that the HIV-1 Tat protein enhances both mRNA and protein expression for IL-6, MCP-1, ICAM-1 and VCAM-1 in cultured KS cells. Although Tat has been shown to induce IL-6, ICAM-1 and VCAM-1 expression in other cell types [26, 29] , we provide the first demonstration that Tat induces expression of these genes in KS cells. Furthermore, this is the first report that examines changes in ICAM-1, VCAM-1 and MCP-1 mRNA levels in response to Tat. We demonstrate that the induction of IL-6, ICAM-1 and VCAM-1, but not MCP-1, by Tat occurs much more rapidly than induction by TNFα, an inducer whose action is in large part dependent on the activation of NF-κB. The concentration of Tat that led to increased gene expression in our experiments was within the same range (nanomolar) seen to lead to activation of HIV-1 LTR gene expression and the expression of several cytokines through direct interaction with TAR or TAR-like domains. In contrast, other Tat activities that result from interactions with cell surface proteins such as integrins or the VEGF receptor Flk-1/KDR generally occur at lower (picomolar) concentrations of Tat [31, 32] . These data are suggestive of a mechanism that requires higher concentrations of Tat for uptake and nuclear localization rather than interaction with a cell surface receptor.
We demonstrate that both Tat and TNFα activate NF-κB in KS cells and that the genes induced by Tat all contain NF-κB sites in their promoters. Tat has been shown to activate NF-κB in several other cell types, including HeLa cells and monocytic and lymphocytic cell lines [33] , and activation by Tat was shown to be blocked with inhibitors of the proteosome complex and anti-oxidants [33] , suggesting that activation of NF-κB by Tat shares some common events with other activation pathways for NF-κB. NF-κB activation alone is not sufficient for the induction of the genes reported here since NF-κB was activated by phorbol ester in cultured KS cells but did not induce expression of the inflammatory response genes (data not shown). For all of the genes examined except MCP-1, induction by Tat occurred earlier and with higher peak levels than seen in induction by TNFα. There were no detectable differences in the NF-κB that was activated by Tat and TNFα to explain these differences. For Tat-mediated induction of the cellular genes for TNFβ and IL-6, transactivation involves putative TAR-like regions in the 5Ј UTR sequences of their mRNAs [26, 27, 50] . In addition, Tat complexes with CCAAT Enhancer binding protein β (C/EBPβ), a major mediator of IL-6 promoter function, and enhances its binding to the C/EBP site in the IL-6 promoter. Although VCAM-1 and ICAM-1 mRNA were also shown to be induced more rapidly and to higher levels by Tat than by TNFα, neither of these genes are known to contain The effect of HIV-1 Tat and tumour necrosis factor (TNF) on NF-κB binding activity in Kaposi's sarcoma (KS) cells. Nuclear extracts were prepared from confluent KS cells that were untreated or incubated with Tat (0.1 µg/ml) or TNFα (10 ng/ml) for 2 h. The extracts (10 µg) were incubated with a 32 P-labelled vascular cell adhesion molecule 1 (VCAM-1) NF-κB oligonucleotide probe and fractionated on a non-denaturing acrylamide gel as described in the Methods. Complexes denoted as 'A' and 'B' represent NF-κB complexes specifically competed away by a 100-fold excess of cold NF-κB probe but not by an unrelated cold oligonucleotide probe. Supershift analysis was performed by the inclusion of antibody (1 µg) to p50 or p65 subunits during incubation. C/EBP elements or TAR-like regions. Coimmunoprecipitation studies in other cells demonstrate that Tat can interact directly with several components of the transcription machinery including TFIID, Sp1 and NF-κΒ [51, 52] . Whether such interactions are involved in the early induction of these genes by Tat remains to be determined.
As we have previously reported, some, if not all, of the cultured AIDS-KS cell lines used in these studies contain HHV8 [42] . Reports from other laboratories have shown an absence of HHV8 genomic sequences in many AIDS-KS spindle cell cultures [53, 54] . Differences in isolation technique and culture conditions may contribute to these differences in HHV8 content. Whether the presence of HHV8 has any effect on the responses to Tat is under investigation.
KS develops more commonly in HIV-infected individuals, but it also occurs in individuals that are not HIV-1 infected, suggesting that although HIV gene products may increase the risk for the development of KS, they are not an absolute requirement. Despite the lack of a signal sequence, extracellular Tat can be released from cells and taken up by neighbouring cells [13] . Our results identify several genes in KS cells that are induced by Tat and whose expression might contribute to the development of AIDS-KS. The HIV-infected leukocytes that are characteristically found in AIDS-KS lesions could provide Tat, which could increase expression of IL-6, a cytokine that activates leukocytes and induces the proliferation of KS cells. Induction of the chemokine MCP-1 and of cellular adhesion molecules on the surface of KS cells could promote further leukocytic infiltration. These infiltrated leukocytes could provide additional Tat and cytokines to KS cells as well as providing leukocytes infected with HHV8. Therefore, although Tat is not required for the development of KS, the ability of Tat to induce directly proinflammatory and proproliferative genes in KS could contribute to the pathogenic process.
